123 related articles for article (PubMed ID: 11118569)
1. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.
Vaquero J; Zurita M; Coca S; Oya S; Morales C
Surg Neurol; 2000 Sep; 54(3):229-34; discussion 234. PubMed ID: 11118569
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival.
Varlet P; Guillamo JS; Nataf F; Koziak M; Beuvon F; Daumas-Duport C
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):379-89. PubMed ID: 10931372
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) likely contributes to oligodendroglioma angiogenesis.
Christov C; Gherardi RK
Acta Neuropathol; 1999 Apr; 97(4):429-32. PubMed ID: 10208285
[No Abstract] [Full Text] [Related]
6. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
7. Expression and distribution of vascular endothelial growth factor protein in human brain tumors.
Pietsch T; Valter MM; Wolf HK; von Deimling A; Huang HJ; Cavenee WK; Wiestler OD
Acta Neuropathol; 1997 Feb; 93(2):109-17. PubMed ID: 9039457
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.
Chaudhry IH; O'Donovan DG; Brenchley PE; Reid H; Roberts IS
Histopathology; 2001 Oct; 39(4):409-15. PubMed ID: 11683943
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in oligodendroglioma.
Schiffer D; Dutto A; Cavalla P; Bosone I; Chiò A; Villani R; Bellotti C
Can J Neurol Sci; 1997 Nov; 24(4):313-9. PubMed ID: 9398978
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
Korshunov A; Golanov A; Sycheva R
J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas.
Christov C; Adle-Biassette H; Le Guerinel C; Natchev S; Gherardi RK
Neuropathol Appl Neurobiol; 1998 Feb; 24(1):29-35. PubMed ID: 9549726
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.
Korshunov A; Golanov A
J Neurooncol; 2000 May; 48(1):13-9. PubMed ID: 11026692
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor-enhancement and angiogenesis in oligodendroglioma.
Vaquero J; Zurita M; Morales C; Coca S
Acta Neurol Scand; 2002 Jul; 106(1):19-23. PubMed ID: 12067323
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
Korshunov A; Golanov A
Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas.
Vaquero J; Zurita M; Morales C; Coca S
Br J Neurosurg; 2001 Jun; 15(3):247-50. PubMed ID: 11478061
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor - its relation to neovascularization and their significance as prognostic factors in renal cell carcinoma.
Song KH; Song J; Jeong GB; Kim JM; Jung SH; Song J
Yonsei Med J; 2001 Oct; 42(5):539-46. PubMed ID: 11675683
[TBL] [Abstract][Full Text] [Related]
17. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
[TBL] [Abstract][Full Text] [Related]
19. Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma.
Quon H; Hasbini A; Cougnard J; Djafari L; Lacroix C; Abdulkarim B
J Neurooncol; 2010 Jan; 96(2):277-85. PubMed ID: 19618120
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase expression of oligodendrogliomas.
Broholm H; Braendstrup O; Lauritzen M
Clin Neuropathol; 2001; 20(6):233-8. PubMed ID: 11758777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
